Article
Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping.
Viruses - 27 Jun 2020
Parkin Neil T, Avila-Rios Santiago, Bibby David F, Brumme Chanson J, Eshleman Susan H, Harrigan P Richard, Howison Mark, Hunt Gillian, Ji Hezhao, Kantor Rami, Ledwaba Johanna, Lee Emma R, Matías-Florentino Margarita, Mbisa Jean L, Noguera-Julian Marc, Paredes Roger, Rivera-Amill Vanessa, Swanstrom Ronald, Zaccaro Daniel J, Zhang Yinfeng, Zhou Shuntai, Jennings Cheryl
Abstract excerpt
Next-generation sequencing (NGS) is increasingly used for HIV-1 drug resistance genotyping. NGS methods have the potential for a more sensitive detection of low-abundance variants (LAV) compared to standard Sanger sequencing (SS) methods. A standardized threshold for reporting LAV that generates data comparable to those derived from SS is needed to allow for the comparability of data from laboratories using NGS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
